October is set to be a busy and strategic month for Biofarma Group, with a prominent presence at three major international trade events in the healthcare sector.
From October 27 to 30, the Group will be in Riyadh to participate in the Global Health Exhibition, a key meeting point for leading public and private stakeholders in the industry, where the challenges and future of global healthcare will be discussed.
From October 28 to 30, Biofarma will attend CPHI Frankfurt, the epicenter of the international pharmaceutical industry, to showcase its cutting-edge solutions in the nutraceutical and medical device fields.
Finally, on October 29 and 30, the Group will be in Las Vegas for SupplySide Global, the leading event for innovation in dietary supplements, functional foods, and health beverages.
Participation in these events highlights Biofarma Group’s commitment to strengthening its global presence, offering tailored health and wellness solutions based on scientific expertise, strategic vision, and strong industrial capabilities.
At both CPHI and the Global Health Exhibition, Biofarma Group will highlight its extensive know-how in the development of nutraceutical products and medical devices, with a portfolio of ready-to-market solutions and highly customizable services.
The Group will present a comprehensive catalog of medical devices, available in both solid and liquid forms, designed for the prevention, diagnosis, and treatment of a wide range of conditions.
The therapeutic areas covered include intimate health, gastrointestinal health, respiratory health, joint health and dermatology. All products are ready-to-market, available for out-licensing, and feature high safety, efficacy, and tolerability profiles.
In the nutraceutical segment, Biofarma will showcase a range of dietary supplements developed to meet the most current consumer needs, including mental health, immune support, digestive wellness, women’s health, beauty from within. These formulations are backed by strong scientific evidence and enhanced by innovative, safe, and effective technologies, such as:
M-Cap® & Dry-Cap
T-win®
Microencapsulation
Tablets (multilayer, ODT, effervescent, mini-tablets)
Beadlets
Stick packs
At SupplySide Global in Las Vegas, the spotlight will be on US Pharma Lab, Biofarma Group’s U.S. subsidiary, which acts as a bridge between the Group’s global expertise and the American market.
US Pharma Lab will present an overview of the Group’s most advanced nutraceutical technologies, including:
Capsules
Tablets (including multilayer, chewable, ODT, and effervescent formats)
Specialized technologies such as beadlets and mini-tablets
Customizable powders
Liquid formulations
Also on display will be the Group’s distinctive capabilities in selecting and granulating high-value ingredients, such as: botanical extracts, amino acids, micronized vitamins and minerals, functional premixes.
Thanks to cutting-edge production technologies – including high-shear granulators, planetary mixers, and fluid bed dryers – the US Pharma Lab team can expertly handle even the most complex active ingredients, ensuring precision, quality, and industrial scalability.
